Monthly Archives: February 2018

//February

PMPRB Patient Group Consultation Submission

Patient Groups send a strong message to the Federal Minister of Health: Patient voices must be heard. We ask the @CDNMinHealth to halt the review of drug prices and move to [...]

By | 2018-05-07T18:28:10+00:00 February 15th, 2018|News|Comments Off on PMPRB Patient Group Consultation Submission

Health Canada approves Ipsen’s Somatuline® Autogel® for the treatment of carcinoid syndrome in adult patients with neuroendocrine tumours (NETs)

Somatuline Autogel is the first and only somatostatin analog (SSA) approved in Canada to treat enteropancreatic neuroendocrine tumours and carcinoid syndrome. Februaury 13th, 2018 - Health Canada announced the approval [...]

By | 2018-05-07T18:28:10+00:00 February 13th, 2018|Treatment News|Comments Off on Health Canada approves Ipsen’s Somatuline® Autogel® for the treatment of carcinoid syndrome in adult patients with neuroendocrine tumours (NETs)

Raising NET Cancer Awareness on World Cancer Day

CNETS Canada Montreal Support Group Leaders Donna Hillier, Daniel Opoku and volunteer Marie-Anne Risdon set up a kiosk at the Ceders Cancer Foundation - CEDARS CANSUPPORT WORLD CANCER DAY, providing [...]

By | 2018-05-07T18:28:10+00:00 February 6th, 2018|News|Comments Off on Raising NET Cancer Awareness on World Cancer Day